Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 3/20 | 0.55 |
| ▸ | NOS1 | P29475 | 3/20 | 0.55 |
| ▸ | NOS2 | P35228 | 3/20 | 0.55 |
| ▸ | SLC7A5 | Q01650 | 8/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.50 |
| ▸ | ALPI | P09923 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | XIAP | P98170 | 1/20 | 0.50 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29551024 | 1.00 | NOS3 (0.55) | NOS3NOS1NOS2SLC7A5PTGS1 | |
| SCHEMBL22689734 | 1.00 | NOS3 (0.55) | NOS3NOS1NOS2SLC7A5PTGS1 | |
| SCHEMBL22690015 | 0.90 | NOS3 (0.53) | NOS3NOS1NOS2SLC7A5PTGS1 | |
| SCHEMBL22690014 | 0.90 | NOS3 (0.53) | NOS3NOS1NOS2SLC7A5PTGS1 | |
| SCHEMBL29549928 | 0.88 | NOS3 (0.51) | NOS3NOS1NOS2SLC7A5PTGS1 | |
| SCHEMBL22690396 | 0.88 | NOS3 (0.51) | NOS3NOS1NOS2SLC7A5PTGS1 | |
| SCHEMBL22690395 | 0.88 | NOS3 (0.51) | NOS3NOS1NOS2SLC7A5PTGS1 | |
| SCHEMBL22689929 | 0.87 | NOS3 (0.55) | NOS3NOS1NOS2SLC7A5PTGS1 | |
| SCHEMBL22689783 | 0.87 | NOS3 (0.55) | NOS3NOS1NOS2SLC7A5PTGS1 | |
| SCHEMBL22689927 | 0.87 | NOS3 (0.55) | NOS3NOS1NOS2SLC7A5PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12460317-B2 | Genetically encoded, phage-displayed cyclic peptide library and methods of making the same | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2025-11-04 | — | — | US | disclosed |
| US-20230139680-A1 | A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2023-05-04 | — | — | US | disclosed |
| EP-3972625-A1 | A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME | The Texas A&M University System (US) | 2022-03-30 | — | — | EP | disclosed |
| CN-113727725-A | Genetically encoded phage-displayed cyclic peptide libraries and methods of making the same | 得克萨斯A&M大学系统 | 2021-11-30 | — | — | CN | disclosed |
| WO-2020236146-A1 | A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2020-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230139680-A1 | A GENETICALLY ENCODED, PHAGE-DISPLAYED CYCLIC PEPTIDE LIBRARY AND METHODS OF MAKING THE SAME | QPCTL, LNPEP, QPCT | NOS3 2430/4885NOS1 2420/4885NOS2 2097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.